2014
DOI: 10.1016/j.vacun.2014.02.002
|View full text |Cite
|
Sign up to set email alerts
|

Calendario de vacunaciones de la Asociación Española de Pediatría: recomendaciones 2014

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0
2

Year Published

2014
2014
2019
2019

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 103 publications
0
1
0
2
Order By: Relevance
“…Infants born to Tdapvaccinated mothers had significantly higher titers of B. pertussis antibodies than those born to unvaccinated mothers [3]. Consequently, many countries including the UK, USA, Spain, Italy, Belgium and Argentina have implemented the Tdap vaccination during pregnancy in their national immunization programs in order to increase the maternal B. pertussis antibody levels which will be transplacentally transferred to protect the newborn during the first months of life [4][5][6]. High titers of naturally-acquired maternal-derived B. pertussis antibodies have been shown to interfere with the infant humoral immune response induced by the whole cell pertussis (wP) but not to acellular pertussis (aP) vaccine [7].…”
Section: Introductionmentioning
confidence: 99%
“…Infants born to Tdapvaccinated mothers had significantly higher titers of B. pertussis antibodies than those born to unvaccinated mothers [3]. Consequently, many countries including the UK, USA, Spain, Italy, Belgium and Argentina have implemented the Tdap vaccination during pregnancy in their national immunization programs in order to increase the maternal B. pertussis antibody levels which will be transplacentally transferred to protect the newborn during the first months of life [4][5][6]. High titers of naturally-acquired maternal-derived B. pertussis antibodies have been shown to interfere with the infant humoral immune response induced by the whole cell pertussis (wP) but not to acellular pertussis (aP) vaccine [7].…”
Section: Introductionmentioning
confidence: 99%
“…Ensayos de opsonofagocitosis (OPA) mostraron, adicionalmente, una funcionalidad adecuada de los anticuerpos generados con esta estrategia. Estos resultados avalan su indicación en párvulos y adolescentes con SD, como recomienda el CAV-AEP 12 . La pauta más utilizada comprende la aplicación sistemática de la serie infantil estándar con la VNC13, seguida, entre los dos y los cinco años de edad, de una dosis de VNP23.…”
Section: Enfermedad Neumocócicaunclassified
“…Se comentan a continuación las que cabe considerar en niños con SD en relación a las enfermedades prevenibles mediante vacunas, y a partir de las recomendaciones del Comité Asesor de Vacunas de la Asociación Española de Pediatría (CAV-AEP) 12 , advirtiendo de que algunas de ellas cuentan con insuficientes pruebas objetivas y están basadas en datos indirectos y presunciones que se estiman razonables (Tabla 1).…”
unclassified